All stock lists
Xcel Energy Inc (NASDAQ:XEL)
US · Delayed Price · Currency is USD
Also listed: 0M1R.LUtilities · Regulated Electric
77.64-0.41 (-0.53%)
Market cap
$48.5B
Health Score
Analyst consensus
Listed since
Mar 13, 2001
Website
Insider Score
––Not scored
XEL Insider Score
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
XEL analyst forecast
XEL analyst consensus
Moderate Buy5 ratings
Buy 4 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
XEL 12-month price target
$88.73+14.3% upsideaverage of 11 firms
$99.00High
$77.00Low
Best analysts covering XEL
- Evercore ISI Group100%success rate · 4 calls
- Barclays78%success rate · 9 calls
- Keybanc60%success rate · 15 calls
- Mizuho50%success rate · 8 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
XEL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-10-21 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-10-20 |
| BTIG | — | $91.00 | +21.1% | — | 2026-10-20 | |
| Jefferies | — | $99.00 | +31.8% | — | 2026-10-20 | |
| Barclays | Overweight | $85.00 | +12.8% | Reiterated | 2026-10-15 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-14 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-13 |
| KeyBanc | — | $87.00 | +17.3% | — | 2026-10-13 | |
| Scotiabank | — | $77.00 | +11.0% | — | 2026-09-29 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-09-18 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-08-21 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-13 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-07-22 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-07-16 |
| Barclays | Overweight | $90.00 | +13.7% | Reiterated | 2026-07-09 | |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-06-23 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-18 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-12 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-05-04 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-04-22 |
| Barclays | Overweight | $91.00 | +12.2% | Reiterated | 2026-04-21 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-04-21 |
| UBS | Buy | $91.00 | +11.3% | Reiterated | 2026-04-20 | |
| Truist Financial | — | $95.00 | +18.3% | — | 2026-04-20 | |
| — | UBS | Buy | — | — | Reiterated | 2026-03-24 |
| Argus Research | — | $86.00 | +6.2% | — | 2026-03-12 | |
| UBS | Buy | $89.00 | +12.7% | Upgraded | 2026-02-13 | |
| RBC Capital | — | $95.00 | +27.6% | — | 2026-01-23 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-15 |
| Mizuho Securities | — | $86.00 | +16.6% | — | 2026-01-09 | |
| UBS | Neutral | $81.00 | +9.9% | Reiterated | 2025-12-17 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-12-12 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-12-11 |
| Morgan Stanley | — | $84.00 | +5.4% | — | 2025-11-20 | |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-05 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-11-03 |
| UBS | Neutral | $86.00 | +5.9% | Reiterated | 2025-10-31 | |
| Mizuho | Outperform | $87.00 | +7.5% | Reiterated | 2025-10-27 | |
| BTIG | — | $96.00 | +19.0% | — | 2025-10-21 | |
| — | Jefferies | Buy | — | — | Reiterated | 2025-10-16 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-10-15 |
| BMO Capital | Outperform | $87.00 | +7.4% | Reiterated | 2025-10-15 | |
| UBS | Neutral | $84.00 | +3.4% | Reiterated | 2025-10-10 | |
| — | Barclays | Overweight | — | — | Reiterated | 2025-09-29 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-09-25 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-09-25 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2025-09-25 |
| UBS | — | $82.00 | +6.1% | — | 2025-09-25 | |
| Mizuho | Outperform | $80.00 | +9.5% | Reiterated | 2025-09-24 | |
| — | BMO Capital | Outperform | — | — | Upgraded | 2025-09-22 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-08-01 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-06-18 |
| Morgan Stanley | Equal Weight | $78.00 | +12.7% | Reiterated | 2025-05-22 | |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-04-28 |
XEL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-05 | 0.96 | 0.96 | $3.63B | $3.56B |
| 2026-04-30 | 0.91 | 0.91 | $4.21B | $4.02B |
| 2026-07-30 | 0.79 | 0.93 | $3.54B | $3.12B |
| 2026-10-29 | 1.39 | 0.00 | $4.26B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.